Skip to main content
Caplight Logo









Juniper Genomics

Juniper Genomics

Private
TorontoHealthcare & Life Scienceshttps://www.junipergenomics.com/

Last Round

Seed

Jun 26, 2025

Total Funding Raised

$4.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Juniper Genomics is a biotechnology company that provides an advanced embryo screening test for in-vitro fertilization (IVF) using whole-genome and transcriptome sequencing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

embryo screeningpreimplantation genetic testingPGTIVF success ratesgenomic analysiswhole genome sequencingtranscriptome sequencingtrio analysisfertility techbioinformaticsprecision medicineembryo viabilityreproductive healthgenetic healthbaby designer tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Juniper Genomics Comparables

Compare Juniper Genomics with similar companies based on industry and business-model similarity.

Juniper Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orchid Health
87%
Genomic Prediction
85%
Progenesis
81%

Juniper Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 26, 2025

Key People

Founding team and executive leadership

Jeremy Grushcow

Founder and CEO

Founding Team

Dan Legault

COO

Executive Team

Kaylene Ready

Chief Product Officer

Executive Team

Juniper Genomics Investors

Notable investors and investment history

Juniper Genomics investors
InvestorRounds
Company VenturesSeed
Company VenturesSeed
Blue CollectiveSeed
VelocitySeed
InnoSpark VenturesSeed
Amboy Street VenturesSeed
FundRxSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 124% MoM, reaching 3.7K.

  • Jun 20, 2026

    Monthly visitors increased 44% MoM.

Juniper Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Juniper Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Juniper Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range17
Year Founded2021
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?